H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)

Go back to H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
(NASDAQ: URGN) Delayed: 41.17 +0.94 (2.34%)
Previous Close $40.23    52 Week High
Open $40.67    52 Week Low
Day High $41.87    P/E N/A 
Day Low $40.23    EPS
Volume 176,153